论文部分内容阅读
美国《科学》杂志报告说,德国科学家已建立了“非典”病毒的蛋白酶模型,对此模型进行的初步分析显示,一种正处于临床试验阶段的感冒药物经改进后也许可用于治疗“非典”。德吕贝克大学长罗尔夫·希尔根费尔德教授和维尔茨堡大学的约翰·齐布尔多年来一直致力于
According to the report of the U.S. Science, German scientists have established a protease model of the “SARS” virus. A preliminary analysis of this model shows that a cold medicine being tested in clinical trials may be used to treat “SARS” . Prof. Rolf Hilfenfeld, of the University of Teutoburger and John Cibour of the University of Würzburg have been working for many years